HAE
Haemonetics Corporation
108.40$
+0.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.2% | -2.5% | +2.0% | +7.0% | +2.2% | -11.9% | +14.1% | +17.7% | +12.0% | +4.0% | -2.0% | |
| – | +5.7% | +0.9% | -3.1% | +11.8% | -9.0% | -11.7% | +4.6% | +18.0% | +9.4% | -2.5% | +1.4% | |
| – | -6.6% | -6.8% | +8.8% | +1.4% | +16.8% | -12.2% | +23.9% | +17.4% | +14.3% | +9.4% | -4.5% | |
| – | +3.1% | -15.4% | -17.0% | -9.0% | +9.4% | +4.0% | +35.8% | +6.2% | +7.5% | +10.1% | -13.9% | |
| – | +21.1% | -4.5% | +4.7% | -6.3% | -10.8% | -0.3% | +25.5% | +11.9% | +12.8% | +0.2% | +6.8% | |
| – | +14.2% | -11.6% | -10.6% | -6.1% | +15.1% | -11.9% | +32.9% | +3.7% | +17.2% | +1.8% | -9.8% | |
| – | -208.4% | – | – | +48.8% | +23.7% | -13.2% | -10.0% | +93.2% | +5.7% | +34.5% | +8.8% | |
| – | +1.1% | -14.6% | -44.1% | +119.0% | +63.4% | +3.9% | +1.7% | -14.5% | -11.0% | -25.1% | +194.5% | |
| – | -271.4% | – | – | +23.5% | +18.4% | -16.3% | -12.7% | +122.2% | +7.4% | +39.6% | -39.6% | |
| – | -84.8% | -155.8% | – | +32.4% | -42.9% | -161.7% | – | +28.4% | +31.9% | +29.4% | -30.8% | |
| – | -429.2% | – | – | +20.7% | +39.1% | +3.8% | -45.4% | +166.1% | +1.9% | +42.6% | -42.0% | |
| – | +1.7% | -4.3% | +24.2% | +26.1% | +33.7% | -28.5% | +4.0% | +31.4% | +17.2% | +20.5% | -12.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.